Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1311783.RAXoKT2n5LQhvNUCe5N9_46h6_vrVQlHEqI2LbllWLc9s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1311783.RAXoKT2n5LQhvNUCe5N9_46h6_vrVQlHEqI2LbllWLc9s130_assertion type Assertion NP1311783.RAXoKT2n5LQhvNUCe5N9_46h6_vrVQlHEqI2LbllWLc9s130_head.
- NP1311783.RAXoKT2n5LQhvNUCe5N9_46h6_vrVQlHEqI2LbllWLc9s130_assertion description "[Immunoperoxidase studies revealed that the majority of ovarian cancer specimens expressed both CD44S and CD44-9v, whereas expression of sequences from variant exons 3, 4, and 6 was uncommon.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311783.RAXoKT2n5LQhvNUCe5N9_46h6_vrVQlHEqI2LbllWLc9s130_provenance.
- NP1311783.RAXoKT2n5LQhvNUCe5N9_46h6_vrVQlHEqI2LbllWLc9s130_assertion evidence source_evidence_literature NP1311783.RAXoKT2n5LQhvNUCe5N9_46h6_vrVQlHEqI2LbllWLc9s130_provenance.
- NP1311783.RAXoKT2n5LQhvNUCe5N9_46h6_vrVQlHEqI2LbllWLc9s130_assertion SIO_000772 7543560 NP1311783.RAXoKT2n5LQhvNUCe5N9_46h6_vrVQlHEqI2LbllWLc9s130_provenance.
- NP1311783.RAXoKT2n5LQhvNUCe5N9_46h6_vrVQlHEqI2LbllWLc9s130_assertion wasDerivedFrom befree-2016 NP1311783.RAXoKT2n5LQhvNUCe5N9_46h6_vrVQlHEqI2LbllWLc9s130_provenance.
- NP1311783.RAXoKT2n5LQhvNUCe5N9_46h6_vrVQlHEqI2LbllWLc9s130_assertion wasGeneratedBy ECO_0000203 NP1311783.RAXoKT2n5LQhvNUCe5N9_46h6_vrVQlHEqI2LbllWLc9s130_provenance.